Finance

Beta
Lists
002349:SHE
Jinghua Pharmaceutical Group Co Ltd
CN¥6.53
-0.31%
(-0.020) 1D
Jun 10, 3:04:48 PM GMT+8  ·   CNY
All symbols
SymbolPriceChange% Change
Generating top insights for 002349...
Open
CN¥6.54
High
CN¥6.66
Low
CN¥6.40
Mkt. cap
5.44B
Avg. vol.
10.81M
Volume
8.11M
Dividend
1.38%
Quarterly dividend
CN¥0.02
Ex-dividend date
May 29, 2026
P/E ratio
23.98
52-wk high
CN¥8.45
52-wk low
CN¥6.40
EPS
CN¥0.27
Shares outstanding
831.13M
No. of employees
1K
Open
CN¥6.54
High
CN¥6.66
Low
CN¥6.40
Mkt. cap
5.44B
Avg. vol.
10.81M
Volume
8.11M
Dividend
1.38%
Quarterly dividend
CN¥0.02
Ex-dividend date
May 29, 2026
P/E ratio
23.98
52-wk high
CN¥8.45
52-wk low
CN¥6.40
EPS
CN¥0.27
Shares outstanding
831.13M
No. of employees
1K
News stories
From sources across the web
About Jinghua Pharmaceutical Group Co Ltd
CEO-
Employees1.46K
Founded1957
Headquarters-
SectorPharmaceutical industry
Previous reportsAll values in CNY
Loading Previous Earnings...
Income statement
Revenue
Net income
All values in CNY
Jun 2025
Sep 2025
Dec 2025
Mar 2026
Revenue
367.89M
360.86M
367.67M
379.76M
Cost of goods sold
168.28M
173.69M
196.06M
169.42M
Cost of revenue
168.28M
173.69M
196.06M
169.42M
Research and development expenses
18.34M
14.70M
21.45M
14.29M
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
97.22M
105.07M
99.33M
96.62M
Operating expense
121.41M
124.89M
125.31M
117.85M
Total operating expenses
289.69M
298.58M
321.37M
287.26M
Operating income
78.20M
62.29M
46.30M
92.50M
Other non operating income
-7.86K
-1.59M
1.52M
-1.45M
EBT including unusual items
91.63M
67.91M
60.56M
94.49M
EBT excluding unusual items
86.21M
70.73M
51.60M
96.81M
Income tax expense
11.46M
10.05M
8.28M
12.74M
Effective tax rate
12.50%
14.79%
13.66%
13.49%
Other operating expenses
5.55M
5.43M
4.59M
5.10M
Net income
68.42M
45.73M
42.91M
65.87M
Net profit margin
18.60%
12.67%
11.67%
17.35%
Earnings per share
-
-
-
-
Interest and investment income
8.71M
9.58M
6.44M
5.88M
Interest expense
-232.87K
-
-115.63K
-116.59K
Net interest expenses
8.48M
9.58M
6.33M
5.77M
Depreciation and amortization charges
-
-
-
-
EBITDA
97.50M
81.02M
66.16M
112.36M
Gain or loss from assets sale
-28.38K
28.38K
5.09K
-
AI content may include mistakes. Learn more

Research

AI content may include mistakes. Learn more